Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Farnesol production from <i>Escherichia coli</i> by harnessing the exogenous mevalonate pathway — Chonglong Wang (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Farnesol production from <i>Escherichia coli</i> by harnessing the exogenous mevalonate pathway
Shared by
Jay D Keasling
University of California, Berkeley
Farnesol production from <i>Escherichia coli</i> by harnessing the exogenous mevalonate pathway
Article
2010
en
Authors
+5 more
CW
Chonglong Wang
SY
Sang‐Hwal Yoon
AS
Asad A. Shah
Abstract
1 min read
Abstract Farnesol (FOH) production has been carried out in metabolically engineered Escherichia coli . FOH is formed through the depyrophosphorylation of farnesyl pyrophosphate (FPP), which is synthesized from isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) by FPP synthase. In order to increase FPP synthesis, E. coli was metabolically engineered to overexpress ispA and to utilize the foreign mevalonate (MVA) pathway for the efficient synthesis of IPP and DMAPP. Two‐phase culture using a decane overlay of the culture broth was applied to reduce volatile loss of FOH produced during culture and to extract FOH from the culture broth. A FOH production of 135.5 mg/L was obtained from the recombinant E. coli harboring the pTispA and pSNA plasmids for ispA overexpression and MVA pathway utilization, respectively. It is interesting to observe that a large amount of FOH could be produced from E. coli without FOH synthase by the augmentation of FPP synthesis. Introduction of the exogenous MVA pathway enabled the dramatic production of FOH by E. coli while no detectable FOH production was observed in the endogenous MEP pathway‐only control. Biotechnol. Bioeng. 2010;107: 421–429. © 2010 Wiley Periodicals, Inc.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2004
Mono and diterpene production in <i>Escherichia coli</i>
K. Kinkead Reiling
,
Yasuo Yoshikuni
,
Vincent J. J. Martin
,
Jack D. Newman
,
Jörg Bohlmann
,
Jay D Keasling
Article
2006
Enhanced lycopene production in <i>Escherichia coli</i> engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate
Sang‐Hwal Yoon
,
Young‐Mi Lee
,
Ju‐Eun Kim
,
Sook‐Hee Lee
,
J.O. Lee
,
Jae‐Yean Kim
,
Kyung‐Hwa Jung
,
Yong‐Chul Shin
,
Jay D Keasling
,
Seon‐Won Kim
Article
2017
Production of jet fuel precursor monoterpenoids from engineered <i>Escherichia coli</i>
Daniel Mendez‐Perez
,
Jorge Alonso-Gutiérrez
,
Qijun Hu
,
Margaux Molinas
,
Edward E. K. Baidoo
,
George Wang
,
Leanne Jade G. Chan
,
Paul D. Adams
,
Christopher J. Petzold
,
Jay D Keasling
,
Taek Soon Lee
Article
2014
A kinetic‐based approach to understanding heterologous mevalonate pathway function in <i>E. coli</i>
Lane J. Weaver
,
Mirta Mittelstedt Leal de Sousa
,
George Wang
,
Edward E. K. Baidoo
,
Christopher J. Petzold
,
Jay D Keasling
Article
2021
Lepidopteran mevalonate pathway optimization in Escherichia coli efficiently produces isoprenol analogs for next-generation biofuels
Bo Pang
,
Jia Li
,
Christopher B. Eiben
,
Ethan Oksen
,
Carolina A. Barcelos
,
Rong Chen
,
Elias Englund
,
Eric Sundström
,
Jay D Keasling
Discussion(0)
No comments yet. Be the first to comment.